ALIGN TECHNOLOGY, INC. Research and Development Expense
ALIGN TECHNOLOGY, INC. (ALGN) reported Research and Development Expense of $102.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. research and development expense for the quarter ending 2026-06-30 was $102.03M, a 5.84% increase year-over-year.
- ALIGN TECHNOLOGY, INC. research and development expense for the quarter ending 2026-03-31 was $98.66M, a 1.50% increase year-over-year.
- ALIGN TECHNOLOGY, INC. research and development expense for the quarter ending 2025-12-31 was $83.04M, a 12.48% decline year-over-year.
- ALIGN TECHNOLOGY, INC. research and development expense for the quarter ending 2025-09-30 was $93.28M, a 9.39% increase year-over-year.
- ALIGN TECHNOLOGY, INC. research and development expense for fiscal 2025 was $369.91M, a 1.57% increase from fiscal 2024.
- ALIGN TECHNOLOGY, INC. research and development expense for fiscal 2024 was $364.20M, a 5.01% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. research and development expense for fiscal 2023 was $346.83M, a 13.62% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. research and development expense for fiscal 2022 was $305.26M, a 21.95% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $102.03M 10-Q · filed 2026-08-05 | $200.69M 10-Q · filed 2026-08-05 | $283.73M derived: sum of 3 quarters · filed 2026-08-05 | $377.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $98.66M 10-Q · filed 2026-05-06 | $181.69M derived: sum of 2 quarters · filed 2026-05-06 | $274.97M derived: sum of 3 quarters · filed 2026-05-06 | $371.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $83.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $176.31M derived: sum of 2 quarters · filed 2026-02-27 | $272.71M derived: sum of 3 quarters · filed 2026-08-05 | $369.91M 10-K · filed 2026-02-27 |
| 2025-09-30 | $93.28M 10-Q · filed 2025-11-05 | $189.67M derived: sum of 2 quarters · filed 2026-08-05 | $286.88M 10-Q · filed 2025-11-05 | $381.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $96.40M 10-Q · filed 2026-08-05 | $193.60M 10-Q · filed 2026-08-05 | $288.48M derived: sum of 3 quarters · filed 2026-08-05 | $373.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $97.20M 10-Q · filed 2026-05-06 | $192.08M derived: sum of 2 quarters · filed 2026-05-06 | $277.35M derived: sum of 3 quarters · filed 2026-05-06 | $369.54M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $94.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $180.15M derived: sum of 2 quarters · filed 2026-02-27 | $272.34M derived: sum of 3 quarters · filed 2026-02-27 | $364.20M 10-K · filed 2026-02-27 |
| 2024-09-30 | $85.27M 10-Q · filed 2025-11-05 | $177.47M derived: sum of 2 quarters · filed 2025-11-05 | $269.32M 10-Q · filed 2025-11-05 | $351.48M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $92.19M 10-Q · filed 2025-08-06 | $184.05M 10-Q · filed 2025-08-06 | $266.21M derived: sum of 3 quarters · filed 2026-02-27 | $354.95M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $91.86M 10-Q · filed 2025-05-08 | $174.02M derived: sum of 2 quarters · filed 2026-02-27 | $262.76M derived: sum of 3 quarters · filed 2026-02-27 | $351.24M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $82.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $170.90M derived: sum of 2 quarters · filed 2026-02-27 | $259.38M derived: sum of 3 quarters · filed 2026-02-27 | $346.83M 10-K · filed 2026-02-27 |
| 2023-09-30 | $88.74M 10-Q · filed 2024-11-05 | $177.22M derived: sum of 2 quarters · filed 2024-11-05 | $264.67M 10-Q · filed 2024-11-05 | $348.19M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $88.48M 10-Q · filed 2024-08-02 | $175.93M 10-Q · filed 2024-08-02 | $259.45M derived: sum of 3 quarters · filed 2025-02-28 | $336.42M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $87.45M 10-Q · filed 2024-05-03 | $170.97M derived: sum of 2 quarters · filed 2025-02-28 | $247.93M derived: sum of 3 quarters · filed 2025-02-28 | $320.90M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $83.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $160.49M derived: sum of 2 quarters · filed 2025-02-28 | $233.45M derived: sum of 3 quarters · filed 2025-02-28 | $305.26M 10-K · filed 2025-02-28 |
| 2022-09-30 | $76.97M 10-Q · filed 2023-11-03 | $149.93M derived: sum of 2 quarters · filed 2023-11-03 | $221.74M 10-Q · filed 2023-11-03 | $294.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $72.97M 10-Q · filed 2023-08-04 | $144.77M 10-Q · filed 2023-08-04 | $217.25M derived: sum of 3 quarters · filed 2024-02-28 | $282.83M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $71.81M 10-Q · filed 2023-05-05 | $144.28M derived: sum of 2 quarters · filed 2024-02-28 | $209.87M derived: sum of 3 quarters · filed 2024-02-28 | $267.58M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $72.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $138.06M derived: sum of 2 quarters · filed 2024-02-28 | $195.78M derived: sum of 3 quarters · filed 2024-02-28 | $250.31M 10-K · filed 2024-02-28 |
| 2021-09-30 | $65.59M 10-Q · filed 2022-11-04 | $123.30M derived: sum of 2 quarters · filed 2022-11-04 | $177.84M 10-Q · filed 2022-11-04 | $226.73M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $57.72M 10-Q · filed 2022-08-04 | $112.25M 10-Q · filed 2022-08-04 | $161.14M derived: sum of 3 quarters · filed 2023-02-27 | $205.67M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $54.54M 10-Q · filed 2022-05-05 | $103.42M derived: sum of 2 quarters · filed 2023-02-27 | $147.95M derived: sum of 3 quarters · filed 2023-02-27 | $188.31M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $48.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $93.41M derived: sum of 2 quarters · filed 2023-02-27 | $133.78M derived: sum of 3 quarters · filed 2023-02-27 | $175.31M 10-K · filed 2023-02-27 |
| 2020-09-30 | $44.53M 10-Q · filed 2021-11-02 | $84.89M derived: sum of 2 quarters · filed 2021-11-02 | $126.42M 10-Q · filed 2021-11-02 | $167.75M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $40.36M 10-Q · filed 2021-08-04 | $81.89M 10-Q · filed 2021-08-04 | $123.22M derived: sum of 3 quarters · filed 2022-02-25 | $162.90M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $41.53M 10-Q · filed 2021-05-05 | $82.86M derived: sum of 2 quarters · filed 2022-02-25 | $122.54M derived: sum of 3 quarters · filed 2022-02-25 | $161.39M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $41.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $81.01M derived: sum of 2 quarters · filed 2022-02-25 | $119.86M derived: sum of 3 quarters · filed 2022-02-25 | $157.36M 10-K · filed 2022-02-25 |
| 2019-09-30 | $39.68M 10-Q · filed 2020-10-30 | $78.53M derived: sum of 2 quarters · filed 2020-10-30 | $116.03M 10-Q · filed 2020-10-30 | $151.84M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $38.85M 10-Q · filed 2020-07-31 | $76.35M 10-Q · filed 2020-07-31 | $112.16M derived: sum of 3 quarters · filed 2021-02-26 | $144.86M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $37.50M 10-Q · filed 2020-05-05 | $73.31M derived: sum of 2 quarters · filed 2021-02-26 | $106.01M derived: sum of 3 quarters · filed 2021-02-26 | $136.81M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $35.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $68.50M derived: sum of 2 quarters · filed 2021-02-26 | $99.31M derived: sum of 3 quarters · filed 2021-02-26 | $128.90M 10-K · filed 2021-02-26 |
| 2018-09-30 | $32.70M 10-Q · filed 2019-10-31 | $63.50M derived: sum of 2 quarters · filed 2019-10-31 | $93.09M 10-Q · filed 2019-10-31 | $119.27M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $30.80M 10-Q · filed 2019-08-01 | $60.40M 10-Q · filed 2019-08-01 | $86.56M derived: sum of 3 quarters · filed 2020-02-28 | $110.77M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $29.59M 10-Q · filed 2019-05-02 | $55.76M derived: sum of 2 quarters · filed 2020-02-28 | $79.96M derived: sum of 3 quarters · filed 2020-02-28 | $104.35M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $26.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $50.37M derived: sum of 2 quarters · filed 2020-02-28 | $74.75M derived: sum of 3 quarters · filed 2020-02-28 | $97.56M 10-K · filed 2020-02-28 |
| 2017-09-30 | $24.20M 10-Q · filed 2018-11-01 | $48.59M derived: sum of 2 quarters · filed 2018-11-01 | $71.39M 10-Q · filed 2018-11-01 | $93.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $24.38M 10-Q · filed 2018-08-02 | $47.19M 10-Q · filed 2018-08-02 | $68.80M derived: sum of 3 quarters · filed 2019-02-28 | $89.21M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $22.80M 10-Q · filed 2018-05-03 | $44.41M derived: sum of 2 quarters · filed 2019-02-28 | $64.83M derived: sum of 3 quarters · filed 2019-02-28 | $83.44M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $21.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $42.02M derived: sum of 2 quarters · filed 2019-02-28 | $60.64M derived: sum of 3 quarters · filed 2019-02-28 | $75.72M 10-K · filed 2019-02-28 |
| 2016-09-30 | $20.41M 10-Q · filed 2017-11-02 | $39.03M derived: sum of 2 quarters · filed 2017-11-02 | $54.11M 10-Q · filed 2017-11-02 | $68.00M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $18.61M 10-Q · filed 2017-08-03 | $33.70M 10-Q · filed 2017-08-03 | $47.59M derived: sum of 3 quarters · filed 2018-02-28 | $65.36M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $15.08M 10-Q · filed 2017-05-04 | $28.97M derived: sum of 2 quarters · filed 2018-02-28 | $46.75M derived: sum of 3 quarters · filed 2018-02-28 | $62.44M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $31.67M derived: sum of 2 quarters · filed 2018-02-28 | $47.35M derived: sum of 3 quarters · filed 2018-02-28 | $61.24M 10-K · filed 2018-02-28 |
| 2015-09-30 | $17.78M 10-Q · filed 2016-11-08 | $33.46M derived: sum of 2 quarters · filed 2016-11-08 | $47.35M 10-Q · filed 2016-11-08 | $60.62M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $15.68M 10-Q · filed 2016-08-04 | $29.57M 10-Q · filed 2016-08-04 | $42.84M derived: sum of 3 quarters · filed 2017-02-28 | $55.70M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $13.88M 10-Q · filed 2016-05-05 | $27.16M derived: sum of 2 quarters · filed 2017-02-28 | $40.02M derived: sum of 3 quarters · filed 2017-02-28 | $53.30M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $13.28M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $26.13M derived: sum of 2 quarters · filed 2017-02-28 | $39.42M derived: sum of 3 quarters · filed 2017-02-28 | $52.80M 10-K · filed 2017-02-28 |
| 2014-09-30 | $12.85M 10-Q · filed 2015-10-29 | $26.14M derived: sum of 2 quarters · filed 2015-10-29 | $39.52M 10-Q · filed 2015-10-29 | $50.49M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $13.29M 10-Q · filed 2015-07-30 | $26.67M 10-Q · filed 2015-07-30 | $37.64M derived: sum of 3 quarters · filed 2016-02-25 | $48.55M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $13.38M 10-Q · filed 2015-05-01 | $24.35M derived: sum of 2 quarters · filed 2016-02-25 | $35.27M derived: sum of 3 quarters · filed 2016-02-25 | $46.18M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $10.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $21.89M derived: sum of 2 quarters · filed 2016-02-25 | $32.80M derived: sum of 3 quarters · filed 2016-02-25 | $44.08M 10-K · filed 2016-02-25 |
| 2013-09-30 | $10.91M 10-Q · filed 2014-10-30 | $21.83M derived: sum of 2 quarters · filed 2014-10-30 | $33.11M 10-Q · filed 2014-10-30 | $44.82M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $10.92M 10-Q · filed 2014-07-31 | $22.20M 10-Q · filed 2014-07-31 | $33.91M derived: sum of 3 quarters · filed 2015-02-26 | $43.86M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $11.28M 10-Q · filed 2014-05-01 | $22.99M derived: sum of 2 quarters · filed 2015-02-26 | $32.95M derived: sum of 3 quarters · filed 2015-02-26 | $43.63M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $11.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $21.66M derived: sum of 2 quarters · filed 2015-02-26 | $32.34M derived: sum of 3 quarters · filed 2015-02-26 | $42.87M 10-K · filed 2015-02-26 |
| 2012-09-30 | $9.95M 10-Q · filed 2013-11-01 | $20.63M derived: sum of 2 quarters · filed 2013-11-01 | $31.16M 10-Q · filed 2013-11-01 | $40.73M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $10.68M 10-Q · filed 2013-08-02 | $21.21M 10-Q · filed 2013-08-02 | $30.77M derived: sum of 3 quarters · filed 2014-02-28 | $39.70M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $10.53M 10-Q · filed 2013-05-03 | $20.09M derived: sum of 2 quarters · filed 2014-02-28 | $29.02M derived: sum of 3 quarters · filed 2014-02-28 | $38.29M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $9.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $18.49M derived: sum of 2 quarters · filed 2014-02-28 | $27.76M derived: sum of 3 quarters · filed 2014-02-28 | $37.15M 10-K · filed 2014-02-28 |
| 2011-09-30 | $8.93M 10-Q · filed 2012-11-09 | $18.20M derived: sum of 2 quarters · filed 2012-11-09 | $27.59M 10-Q · filed 2012-11-09 | $34.48M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $9.27M 10-Q · filed 2012-08-02 | $18.66M 10-Q · filed 2012-08-02 | $25.55M derived: sum of 3 quarters · filed 2013-03-01 | $32.15M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $9.39M 10-Q · filed 2012-05-08 | $16.28M derived: sum of 2 quarters · filed 2013-03-01 | $22.88M derived: sum of 3 quarters · filed 2013-03-01 | $29.27M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $13.48M derived: sum of 2 quarters · filed 2013-03-01 | $19.88M derived: sum of 3 quarters · filed 2013-03-01 | $26.00M 10-K · filed 2013-03-01 |
| 2010-09-30 | $6.59M 10-Q · filed 2011-11-04 | $12.99M derived: sum of 2 quarters · filed 2011-11-04 | $19.10M 10-Q · filed 2011-11-04 | $24.89M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $6.40M 10-Q · filed 2011-08-08 | $12.51M 10-Q · filed 2011-08-08 | $18.29M derived: sum of 3 quarters · filed 2012-02-29 | $23.90M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $6.12M 10-Q · filed 2011-05-05 | $11.90M derived: sum of 2 quarters · filed 2012-02-29 | $17.51M derived: sum of 3 quarters · filed 2012-02-29 | $23.18M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $11.39M derived: sum of 2 quarters · filed 2012-02-29 | $17.06M derived: sum of 3 quarters · filed 2012-02-29 | $22.25M 10-K · filed 2012-02-29 |
| 2009-09-30 | $5.61M 10-Q · filed 2010-11-04 | $11.28M derived: sum of 2 quarters · filed 2010-11-04 | $16.47M 10-Q · filed 2010-11-04 | |
| 2009-06-30 | $5.67M 10-Q · filed 2010-08-05 | $10.86M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $26.16M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |